Research Interests
- Development and evaluation of clinical outcomes assessments (COAs), including patient-reported outcomes (PRO) measures using psychometric and qualitative methods
- To enhance the assessment of physical function and related constructs to inform decision-making
- Methods to improve interpretability of clinical outcomes assessment (COA) scores, including meaningful differences and meaningful change
- Development of screening questionnaires for use in clinical care to support patient-centered care and decision-making
- Evaluating the impact of PRO measures in clinical care on patient outcomes and resource utilization
- Patient goals
- Recall periods (how far back we ask participants to think about their experiences in COAs)
Selected Grants
FDA - BAA Clinical Evidence on the impact of osseointegrated limb prostheses
ResearchCo Investigator · Awarded by Food and Drug Administration · 2023 - 2026A Clinical Trial Readiness Study of Patient Reported Outcome Measures in Thrombotic Thrombocytopenic Purpura (TTP)
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2024 - 2026Evaluation of Unilateral vs Bilateral Hearing Aids for the Treatment of Age-related Hearing Loss
ResearchCo Investigator · Awarded by Patient-Centered Outcomes Research Institute · 2021 - 2026RFTOP 2022 Domain 5-E003 Strategic Use of Race, Ethnicity, and Social Determinants of Health Data in National Healthcare Safety Network (NHSN) Measures to Promote Health Equity
ResearchSenior Research Scientist · Awarded by Centers for Disease Control and Prevention · 2022 - 2025Optimizing the Management and Outcomes for Cancer Survivors Transitioning to Follow-up Care
ResearchCo Investigator · Awarded by National Cancer Institute · 2020 - 2025FDA - BAA Clinical Evidence on the impact of osseointegrated limb prostheses
ResearchCo Investigator · Awarded by Food and Drug Administration · 2023 - 2026A Clinical Trial Readiness Study of Patient Reported Outcome Measures in Thrombotic Thrombocytopenic Purpura (TTP)
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2024 - 2026Evaluation of Unilateral vs Bilateral Hearing Aids for the Treatment of Age-related Hearing Loss
ResearchCo Investigator · Awarded by Patient-Centered Outcomes Research Institute · 2021 - 2026RFTOP 2022 Domain 5-E003 Strategic Use of Race, Ethnicity, and Social Determinants of Health Data in National Healthcare Safety Network (NHSN) Measures to Promote Health Equity
ResearchSenior Research Scientist · Awarded by Centers for Disease Control and Prevention · 2022 - 2025Optimizing the Management and Outcomes for Cancer Survivors Transitioning to Follow-up Care
ResearchCo Investigator · Awarded by National Cancer Institute · 2020 - 2025Migraine Study - Godley Gift
ResearchCo-Principal Investigator · Awarded by Frederick Godley, III · 2021 - 2024Recall of patient-reported symptoms and function in episodic disease/conditions including TMJ
ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2023 - 2024Evaluating physical functioning using patient-reported outcome measures: How does the question form and recall period influence patients' interpretation?
ResearchPrincipal Investigator · Awarded by Food and Drug Administration · 2020 - 2023Gathering Evidence to Determine Whether Modifications are Necessary to the Kansas City Cardiomyopathy Questionnaire (KCCQ) to Address Possible Interpretation Differences by Men and Women
ResearchPrincipal Investigator · Awarded by Food and Drug Administration · 2019 - 2022A novel approach to measuring and managing chronic pain, fatigue, and depression in systemic lupus erythematosus.
Clinical TrialScientist · Awarded by Pfizer, Inc. · 2019 - 2022Evaluating Outcomes of the Rosalynn Carter Institute for Caregiving (RCI) Caregiver Support Programs
ResearchCo Investigator · Awarded by Georgia Southwestern Foundation, Inc. · 2020 - 2021External Relationships
- ISPOR
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.